ClearPoint Neuro, Inc. (CLPT) Q1 2026 Earnings Call Transcript
Clearpoint Neuro Inc CLPT
$11.17
▲ +0.36%
(+$0.04)
Open
$11.07
Prev Close
$11.13
Day Range
$10.93 – $11.28
52W Range
$8.27 – $30.10
Market Cap
$334.98M
Beta
1.26
EPS (TTM)
$-0.90
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-07-03 |
| Shares Out. | 29,990,000 |
| Website | clearpointneuro.com/ ↗ |
| Phone | 13026587581 |
Clearpoint Neuro Inc is a publicly traded company under the ticker symbol CLPT on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-05-01)
📰 Latest News for CLPT
ClearPoint Neuro Q1 2026 Earnings Call Transcript
ClearPoint Neuro Reports First Quarter 2026 Results
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint
Earnings Scheduled For May 13, 2026
'Makary's Time Atop FDA Over, Diamantas Named Acting Commissioner' - Politico
'Trump Approves Plan To Fire FDA Commissioner Marty Makary, Sources Say' - CBS
Replimune Group shares are trading lower after HC Wainwright downgraded the stock from Buy to Sell.